VT
FMED icon

Vise Technologies’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Vise Technologies’s Portfolio FMED Stock Details FMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,648
Closed -$234K – 1885
2026
Q1 		$234K Hold
8,648
– – ﹤0.01% 1298
2025
Q4 		$234K Buy
+8,648
New +$233K ﹤0.01% 1308

Other funds holding FMED

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $793M AUM 21.06% 1-Year Est. Return

Vise Technologies's FMED Position: Q2 2026 in Review

Vise Technologies sold out of Fidelity Disruptive Medicine ETF (FMED) in Q2 2026, closing a stake of 8,648 shares — an estimated $234K sold.

Vise Technologies first reported a position in FMED in Q4 2025 and held it in 2 quarters. The position peaked at $234K in Q1 2026. 11 funds tracked by Wall St. Rank hold FMED as of Q2 2026.

  • Vise Technologies reported no remaining Fidelity Disruptive Medicine ETF position as of Q2 2026 after selling out during the quarter.
  • Vise Technologies sold 8,648 Fidelity Disruptive Medicine ETF shares in Q2 2026, an estimated $234K.
  • Vise Technologies first reported a position in Fidelity Disruptive Medicine ETF in Q4 2025 and held it in 2 quarters.
  • Vise Technologies's Fidelity Disruptive Medicine ETF position peaked at $234K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.